Literature DB >> 12093908

Mutations in the RNase H domain of HIV-1 reverse transcriptase affect the initiation of DNA synthesis and the specificity of RNase H cleavage in vivo.

John G Julias1, Mary Jane McWilliams, Stefan G Sarafianos, Edward Arnold, Stephen H Hughes.   

Abstract

Retroviral reverse transcriptases contain a DNA polymerase activity that can copy an RNA or DNA template and an RNase H activity that degrades the viral RNA genome during reverse transcription. RNase H makes both specific and nonspecific cleavages; specific cleavages are used to generate and remove the polypurine tract primer used for plus-strand DNA synthesis and to remove the tRNA primer used for minus-strand DNA synthesis. We generated mutations in an HIV-1-based vector to change amino acids in the RNase H domain that contact either the RNA and DNA strands. Some of these mutations affected the initiation of DNA synthesis, demonstrating an interdependence of the polymerase and RNase H activities of HIV-1 reverse transcription during viral DNA synthesis. The ends of the linear DNA form of the HIV-1 genome are defined by the specific RNase H cleavages that remove the plus- and minus-strand primers; these ends can be joined to form two-long-terminal repeat circles. Analysis of two-long-terminal repeat circle junctions showed that mutations in the RNase H domain affect the specificity of RNase H cleavage.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093908      PMCID: PMC123172          DOI: 10.1073/pnas.142123199

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase.

Authors:  J G Julias; A L Ferris; P L Boyer; S H Hughes
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

2.  Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection.

Authors:  L Li; J M Olvera; K E Yoder; R S Mitchell; S L Butler; M Lieber; S L Martin; F D Bushman
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

3.  Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.

Authors:  A Hizi; C McGill; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Inhibition of RNase H activity and viral replication by single mutations in the 3' region of Moloney murine leukemia virus reverse transcriptase.

Authors:  R Repaske; J W Hartley; M F Kavlick; R R O'Neill; J B Austin
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  Mutational analysis of the ribonuclease H activity of human immunodeficiency virus 1 reverse transcriptase.

Authors:  A Hizi; S H Hughes; M Shaharabany
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

6.  Sequence of the circle junction of human immunodeficiency virus type 1: implications for reverse transcription and integration.

Authors:  J M Whitcomb; R Kumar; S H Hughes
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

7.  Characterization of the block in replication of nucleocapsid protein zinc finger mutants from moloney murine leukemia virus.

Authors:  R J Gorelick; W Fu; T D Gagliardi; W J Bosche; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

8.  Altering the RNase H primer grip of human immunodeficiency virus reverse transcriptase modifies cleavage specificity.

Authors:  Jason W Rausch; Daniela Lener; Jennifer T Miller; John G Julias; Stephen H Hughes; Stuart F J Le Grice
Journal:  Biochemistry       Date:  2002-04-16       Impact factor: 3.162

9.  Dynamics of the HIV-1 reverse transcription complex during initiation of DNA synthesis.

Authors:  J M Lanchy; C Isel; G Keith; S F Le Grice; C Ehresmann; B Ehresmann; R Marquet
Journal:  J Biol Chem       Date:  2000-04-21       Impact factor: 5.157

10.  Circular DNA of human immunodeficiency virus: analysis of circle junction nucleotide sequences.

Authors:  T Hong; K Drlica; A Pinter; E Murphy
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

View more
  57 in total

1.  Effects of mutations in the G tract of the human immunodeficiency virus type 1 polypurine tract on virus replication and RNase H cleavage.

Authors:  John G Julias; Mary Jane McWilliams; Stefan G Sarafianos; W Gregory Alvord; Eddy Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 2.  Viral polymerases.

Authors:  Kyung H Choi
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  The N348I mutation at the connection subdomain of HIV-1 reverse transcriptase decreases binding to nevirapine.

Authors:  Matthew M Schuckmann; Bruno Marchand; Atsuko Hachiya; Eiichi N Kodama; Karen A Kirby; Kamalendra Singh; Stefan G Sarafianos
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

4.  Effects of raltegravir on 2-long terminal repeat circle junctions in HIV type 1 viremic and aviremic patients.

Authors:  Roberta Bona; Silvia Baroncelli; Gabriella D'Ettorre; Mauro Andreotti; Giancarlo Ceccarelli; Piero Filati; Pasqualina Leone; Maria Blasi; Zuleika Michelini; Clementina Maria Galluzzo; Alessandra Mallano; Vincenzo Vullo; Andrea Cara
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-24       Impact factor: 2.205

5.  Correlation of recombinant integrase activity and functional preintegration complex formation during acute infection by replication-defective integrase mutant human immunodeficiency virus.

Authors:  Xiang Li; Yasuhiro Koh; Alan Engelman
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

6.  Identification of highly conserved residues involved in inhibition of HIV-1 RNase H function by Diketo acid derivatives.

Authors:  Angela Corona; Francesco Saverio Di Leva; Sylvain Thierry; Luca Pescatori; Giuliana Cuzzucoli Crucitti; Frederic Subra; Olivier Delelis; Francesca Esposito; Giuseppe Rigogliuso; Roberta Costi; Sandro Cosconati; Ettore Novellino; Roberto Di Santo; Enzo Tramontano
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

7.  Hydrolysis of RNA/DNA hybrids containing nonpolar pyrimidine isosteres defines regions essential for HIV type 1 polypurine tract selection.

Authors:  Jason W Rausch; Jin Qu; Hye Young Yi-Brunozzi; Eric T Kool; Stuart F J Le Grice
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

8.  Mutations in the 5' end of the human immunodeficiency virus type 1 polypurine tract affect RNase H cleavage specificity and virus titer.

Authors:  Mary Jane McWilliams; John G Julias; Stefan G Sarafianos; W Gregory Alvord; Edward Arnold; Stephen H Hughes
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Mutations in the U5 region adjacent to the primer binding site affect tRNA cleavage by human immunodeficiency virus type 1 reverse transcriptase in vivo.

Authors:  Jangsuk Oh; Mary Jane McWilliams; John G Julias; Stephen H Hughes
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

10.  The effects of alternate polypurine tracts (PPTs) and mutations of sequences adjacent to the PPT on viral replication and cleavage specificity of the Rous sarcoma virus reverse transcriptase.

Authors:  Kevin W Chang; Jangsuk Oh; W Gregory Alvord; Stephen H Hughes
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.